Sachin Kolte

Dr. Sachin Kolte

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Annals of Medical and Health Sciences Research
Verified
Journal Article
Open access
PDF file
SKSachin Kolte
Sachin Kolte
JDJs Dhupia
Js Dhupia
SAS Arora
S Arora
Background: Rejecting hemolyzed specimens received for coagulation studies is advised by the Clinical and Laboratory Standards Institute. Receiving such specimens is a common phenomenon in many laboratories. The true impact of hemolysis on coagulation studies is little studied in clinical practice. Aim: The aim of this work is to study the changes occurring in readings of prothrombin time (PT) and activated partial thromboplastin time (aPTT) in hemolyzed samples. Subjects and Methods: A total of 45 blood samples were collected from two groups of healthy donors and patient population. Samples were run for PT and aPTT and then were hemolyzed and again rerun for PT and aPTT. GraphPad Prism 5 (Version 5, USA) was the software used for statistical analysis and paired "t" test was applied with significance level at 0.05. Results: There was trend of increase in the readings of PT and aPTT in normal population and there was trend of decrease in the reading in patient population. The difference between paired samples from group one was not statistically significant, but it was significant in samples from second group. Conclusion: Samples sent for routine screening of coagulation studies with visible hemolysis can be processed for coagulation. There was no difference observed in hemolyzed and non-hemolyzed samples.

5 September 2022 in Cytojournal
Verified
Journal Article
Open access
SKSachin Kolte
Sachin Kolte
SZSufian Zaheer
Sufian Zaheer
DADurre Aden
Durre Aden
SRSunil Ranga
Sunil Ranga
Objectives: Cytological examination of effusion sample is a preliminary and minimally invasive method for the diagnosis of body fluids. Recently, the International System For Reporting Serous Fluid Cytopathology (ISRSFC) and the Indian Academy of Cytologist (IAC) have published guidelines for reporting effusion cytology and calculating the risks of malignancy (ROMs) for each defined category. We report our 2 years of experience in reclassifying and assessing the feasibility of applying ISRFSC and IAC categories to effusion fluid and to provide an estimate of the risk of malignancy for each diagnostic category. Material and Methods: Cytological reports of patients from January 2019 to December 2020 were retrieved and reclassified into a five-tiered classification scheme as per ISRSFC guidelines. Cellblock and immunohistochemistry were performed in selected cases. Clinico radiological and histopathological information were obtained and correlated with the cytological findings wherever available. Results: In the study, 652 cases were included during the 2 years. Out of these, 328 (50.3%) were women and 314 (47.3%) were men. Patient’s ages ranged between 2 92 years with a mean age of 47.4 years. There were 366 (56.1%) cases of ascitic fluid followed by 262 (40.1%) cases of pleural fluid and 24 (3.8%) cases of pericardial fluid in the analysis. Of all the cases, 13 (2%) were non-diagnostic (ND), 464 (71.6%) were negative for malignant (NFM) cells, 16 (2.4%) were atypia of uncertain significance, 31 (4.7%) were suspicious of malignancy, and 125 (19.3%) were malignant. Cellblock was prepared in 65 cases. Lung cancer followed by breast cancer was the most common malignancies involving the pleural effusion and ovarian cancer was the most common cause of peritoneal effusion. ROM for each diagnostic category was 23% for ND, 25% for NFM, 56% for the atypical category, 80.6% in suspicious, and 90% were for positive for malignancy category. Conclusion: The use of a five-tiered system as per the ISRFC and IAC guidelines are feasible for the standardized reporting of effusion samples, thus avoiding subjective variation of reporting.

28 September 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SSSaritha Shamsunder
Saritha Shamsunder
AMArchana Mishra
Archana Mishra
AKAnita Kumar
Anita Kumar
SKSachin Kolte
Sachin Kolte
In low-resource settings, a point-of-care test for cervical cancer screening that can give an immediate result to guide management is urgently needed. A transvaginal digital device, “Smart Scope®” (SS), with an artificial intelligence-enabled auto-image-assessment (SS-AI) feature, was developed. In a single-arm observational study, eligible consenting women underwent a Smart Scope®-aided VIA-VILI test. Images of the cervix were captured using SS and categorized by SS-AI in four groups (green, amber, high-risk amber (HRA), red) based on risk assessment. Green and amber were classified as SS-AI negative while HRA and red were classified as SS-AI positive. The SS-AI-positive women were advised colposcopy and guided biopsy. The cervix images of SS-AI-negative cases were evaluated by an expert colposcopist (SS-M); those suspected of being positive were also recommended colposcopy and guided biopsy. Histopathology was considered a gold standard. Data on 877 SS-AI, 485 colposcopy, and 213 histopathology were available for analysis. The SS-AI showed high sensitivity (90.3%), specificity (75.3%), accuracy (84.04%), and correlation coefficient (0.670, p = 0.0) in comparison with histology at the CINI+ cutoff. In conclusion, the AI-enabled Smart Scope® test is a good alternative to the existing screening tests as it gives a real-time accurate assessment of cervical health and an opportunity for immediate triaging with visual evidence.

1 January 2014 in Journal of Research in Medical Education & Ethics
Verified
Journal Article
Closed access
PDF file
PMPratibha Mane
Pratibha Mane
SKSachin Kolte
Sachin Kolte
Context The need for blood is increasing in all parts of the world. The most important aim of all blood transfusion centres’ is to recruit donors from low-risk groups to donate blood voluntarily and regularly. Aim The aim of the study was to know the knowledge of medical students about blood donation and to identify the factors that motivates or discourages them from donation. Methods This study was carried out amongst all the students of a medical college. A self-assessment questionnaire including statements about blood donation, aimed to know level of knowledge, reasons for donation, and reasons for refraining from donation was distributed among students. Results Out of 572 students, only minority of these students (31.4%) have donated blood previously. Majority of students (68.6%) have not donated blood previously due to lack of initiative. We came to know that altruism is still the driving force for blood donation. There is no significant difference in the level of knowledge of donors and non-donors. Conclusion These non-donors need to be motivated so that a good, safe source of blood can be maintained throughout the year.

1 September 2021 in Indian Journal of Gynecologic Oncology
Verified
Journal Article
Closed access
PDF file
SKSachin Kolte
Sachin Kolte
SNSaba Naaz
Saba Naaz

13 October 2023 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
AKAdil Aziz Khan
Adil Aziz Khan
SASana Ahuja
Sana Ahuja
SZSufian Zaheer
Sufian Zaheer
CACharanjeet Ahluwalia
Charanjeet Ahluwalia
MSMukul Singh
Mukul Singh
SRSunil Ranga
Sunil Ranga